Reply: A Prima Vista Ablation of Ventricular Tachycardia: Should We Abandon the Mapping of VT?

Journal of the American College of Cardiololgy

8 Agosto Ago 2016 one year ago
  • Carbucicchio C, Dello Russo A, Casella M, Tondo C

A reply to a letter by Dr. Lurz and colleagues in regards to the VISTA (Ablation of Clinical Ventricular Tachycardia Versus Addition of Substrate Ablation on the Long Term Success Rate of VT Ablation) trial.

The authors would like to reinforce the concept that the VISTA randomized trial confirms the validity of substrate-based ablation as a better way to perform ischemic VT ablation. The present one is safe and efficacious and therefore valid not only “A PRIMA VISTA.

”Di Biase L, Burkhardt JD, Lakkireddy D, Carbucicchio C, Mohanty S, Mohanty P, Trivedi C, Santangeli P, Bai R, Forleo G, Horton R, Bailey S, Sanchez J, Al-Ahmad A, Hranitzky P, Gallinghouse GJ, Pelargonio G, Hongo RH, Beheiry S, Hao SC, Reddy M, Rossillo A, Themistoclakis S, Dello Russo A, Casella M, Tondo C, Natale A. J Am Coll Cardiol 2016;68(6):670-1.

Go to PubMed